212 related articles for article (PubMed ID: 11517321)
21. Heterogeneity in antigen processing by different types of antigen-presenting cells. Effect of cell culture on antigen processing ability.
Vidard L; Rock KL; Benacerraf B
J Immunol; 1992 Sep; 149(6):1905-11. PubMed ID: 1517561
[TBL] [Abstract][Full Text] [Related]
22. The response of T cells to soluble protein antigens and fixed antigen-presenting cells.
Bujdoso R; Munro AJ
Immunology; 1986 Sep; 59(1):51-5. PubMed ID: 2428735
[TBL] [Abstract][Full Text] [Related]
23. DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells.
Fredriksen AB; Sandlie I; Bogen B
Mol Ther; 2006 Apr; 13(4):776-85. PubMed ID: 16414309
[TBL] [Abstract][Full Text] [Related]
24. The choice between two distinct T cell determinants within a 23-amino acid region of lysozyme depends on their structural context.
Shastri N; Gammon G; Horvath S; Miller A; Sercarz EE
J Immunol; 1986 Aug; 137(3):911-5. PubMed ID: 2424989
[TBL] [Abstract][Full Text] [Related]
25. Formation of supramolecular activation clusters on fresh ex vivo CD8+ T cells after engagement of the T cell antigen receptor and CD8 by antigen-presenting cells.
Potter TA; Grebe K; Freiberg B; Kupfer A
Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12624-9. PubMed ID: 11606747
[TBL] [Abstract][Full Text] [Related]
26. A functional recombinant single-chain T cell receptor fragment capable of selectively targeting antigen-presenting cells.
Epel M; Ellenhorn JD; Diamond DJ; Reiter Y
Cancer Immunol Immunother; 2002 Nov; 51(10):565-73. PubMed ID: 12384808
[TBL] [Abstract][Full Text] [Related]
27. Vaccination with poly-L-arginine as immunostimulant for peptide vaccines: induction of potent and long-lasting T-cell responses against cancer antigens.
Mattner F; Fleitmann JK; Lingnau K; Schmidt W; Egyed A; Fritz J; Zauner W; Wittmann B; Gorny I; Berger M; Kirlappos H; Otava A; Birnstiel ML; Buschle M
Cancer Res; 2002 Mar; 62(5):1477-80. PubMed ID: 11888923
[TBL] [Abstract][Full Text] [Related]
28. Enumeration of antigen-presenting cells in mice infected with Sendai virus.
Usherwood EJ; Hogg TL; Woodland DL
J Immunol; 1999 Mar; 162(6):3350-5. PubMed ID: 10092789
[TBL] [Abstract][Full Text] [Related]
29. Sensitive visualization of peptide presentation in vitro and ex vivo.
Kunkel D; Kirchhoff D; Volkmer-Engert R; Radbruch A; Scheffold A
Cytometry A; 2003 Jul; 54(1):19-26. PubMed ID: 12820117
[TBL] [Abstract][Full Text] [Related]
30. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.
Lev A; Denkberg G; Cohen CJ; Tzukerman M; Skorecki KL; Chames P; Hoogenboom HR; Reiter Y
Cancer Res; 2002 Jun; 62(11):3184-94. PubMed ID: 12036932
[TBL] [Abstract][Full Text] [Related]
31. T-cell recognition of lysozyme. I. Localization of regions stimulating T-cell proliferative response by synthetic overlapping peptides encompassing the entire molecule.
Bixler GS; Yoshida T; Atassi MZ
Exp Clin Immunogenet; 1984; 1(2):99-111. PubMed ID: 6400996
[TBL] [Abstract][Full Text] [Related]
32. Induction of T cell-mediated immunity using a c-Myb DNA vaccine in a mouse model of colon cancer.
Williams BB; Wall M; Miao RY; Williams B; Bertoncello I; Kershaw MH; Mantamadiotis T; Haber M; Norris MD; Gautam A; Darcy PK; Ramsay RG
Cancer Immunol Immunother; 2008 Nov; 57(11):1635-45. PubMed ID: 18386000
[TBL] [Abstract][Full Text] [Related]
33. Mapping of the antibody and T cell recognition profiles of the HN domain (residues 449-859) of the heavy chain of botulinum neurotoxin A in two high-responder mouse strains.
Dolimbek GS; Dolimbek BZ; Aoki KR; Atassi MZ
Immunol Invest; 2005; 34(2):119-42. PubMed ID: 15921155
[TBL] [Abstract][Full Text] [Related]
34. A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge.
Deliyannis G; Boyle JS; Brady JL; Brown LE; Lew AM
Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6676-80. PubMed ID: 10823919
[TBL] [Abstract][Full Text] [Related]
35. HEL-Flu: an influenza virus containing the hen egg lysozyme epitope recognized by CD4+ T cells from mice transgenic for an alphabeta TCR.
Walker WS; Castrucci MR; Sangster MY; Carson RT; Kawaoka Y
J Immunol; 1997 Sep; 159(6):2563-6. PubMed ID: 9300673
[TBL] [Abstract][Full Text] [Related]
36. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
Dobaño C; Doolan DL
Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
[TBL] [Abstract][Full Text] [Related]
37. Sequential priming and boosting with heterologous HIV immunogens predominantly stimulated T cell immunity against conserved epitopes.
Xu J; Ren L; Huang X; Qiu C; Liu Y; Liu Y; Shao Y
AIDS; 2006 Nov; 20(18):2293-303. PubMed ID: 17117015
[TBL] [Abstract][Full Text] [Related]
38. Antibody-mediated delivery of antigen to chemokine receptors on antigen-presenting cells results in enhanced CD4+ T cell responses.
Schjetne KW; Gundersen HT; Iversen JG; Thompson KM; Bogen B
Eur J Immunol; 2003 Nov; 33(11):3101-8. PubMed ID: 14579278
[TBL] [Abstract][Full Text] [Related]
39. Synthetic CD4+ T cell-targeted antigen-presenting cells elicit protective antitumor responses.
Caserta S; Alessi P; Guarnerio J; Basso V; Mondino A
Cancer Res; 2008 Apr; 68(8):3010-8. PubMed ID: 18413771
[TBL] [Abstract][Full Text] [Related]
40. Differential susceptibility of naïve versus cloned CD4+ T cells to antigen-specific and MHC-restricted anergy induction.
Liu QS; Zhang RH; Chu YW; Xiong SD
Sheng Li Xue Bao; 2003 Dec; 55(6):633-40. PubMed ID: 14695478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
